Partner

At a glance

2

Finished Products

1

Therapy Areas

3+

Delivery Formats

C3-CURA™

Primary Platform

All ingredients
MoringaIngredient · 08/14

Moringa

Flavonoid scaffold – Moringa

Market Landscape

The opportunity – and where the market falls short.

  • 01Nutrient-dense superfood – vitamins, minerals, amino acids, antioxidants
  • 02Metabolic benefits – glucose, lipids, inflammation, vitality
  • 03Daily-use potential for preventive supplementation
  • 04Growing demand in wellness and superfood markets
  • 05Powder-heavy, brand-led positioning
The Stabicon Edge

From market limitation to measurable transformation.

Market LimitationStabicon TransformationImpact
Limited Clinical PositioningCondition-Specific Design – metabolic health, energy, immunityStronger therapeutic relevance
Format LimitationsMulti-Format Delivery – sachets, tablets, capsules, blendsExpanded usability
Low Bioavailability FocusStandardized ExtractsConsistent potency and effectiveness
Compliance ChallengesEasy-to-Consume FormatsBetter adherence
Generic BlendsCombination Strategy with complementary activesDifferentiated formulations
Underutilized PotentialStructured Functional PositioningFull potential in metabolic & preventive health
Stabicon's Portfolio

Moringa reimagined across therapy areas and delivery formats.

2 finished formulations powered by Moringa, organised across 1 therapy category.

02

Products

01

Therapy Areas

03+

Formats

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Unsubscribe in one click. Your email stays with us.

Press Kit

Logos, fact sheet & spokesperson bios – all in one download.

Download Press Kit (ZIP)

For media queries: press@stabicon.com

Accreditations

ISO/IEC 17025:2017 (NABL)WHO Geneva – Audited & ApprovedFSSAI ApprovedCDSCO IndiaUS FDA – Registered FacilityDSIR RegisteredAYUSH Registered

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.